Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Raphaël C.-W. Phan

35 indexed publications match this author name.

ORCID: 0000-0001-7448-4595
OpenAlex: https://openalex.org/A5066166428

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 13 Clinical Trial 10 Depression 9 Receptor Pharmacology 9 End-of-Life Distress 7 Review Article 7 Mechanism of Action 7 Eating Disorders 6 Anxiety 5 Toxicity 4 Pharmacology 4 Treatment-Resistant Depression 4

Journals

Journal of Eating Disorders 2 Journal of Psychedelic Studies 2 Neuroscience Applied 2 Palliative medicine 1 Current Psychiatry Reports 1 Behavioural Pharmacology 1 Healthcare 1 Palliative Medicine Reports 1

Publication history

Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.Palliative medicine · 2026-06-30 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-13 Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under PsilocybinUnknown journal · 2026-04-07 Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”Journal of Eating Disorders · 2026-02-16 Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in ratsBehavioural Pharmacology · 2025-09-24 Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11 Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosaJournal of Eating Disorders · 2025-05-25 Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07 Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16 Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-20 Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31 Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ ConcernsThe Journal of Law Medicine & Ethics · 2024-12-31 Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not helpPsychedelics. · 2024-11-06 What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative studyPalliative & Supportive Care · 2024-09-30 Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-ReportJournal of Palliative Medicine · 2024-09-11 Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15 Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility StudyFOCUS The Journal of Lifelong Learning in Psychiatry · 2024-06-30 Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)Acta Crystallographica Section E Crystallographic Communications · 2024-05-13 Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Unknown journal · 2024-03-31 Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21 Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31 Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesionsEuropean Archives of Psychiatry and Clinical Neuroscience · 2023-11-06 Self-perception and self-recognition while looking in the mirror on psilocybinJournal of Psychedelic Studies · 2023-09-18 Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medicationNeuropsychopharmacology · 2023-07-12 Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31 Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.Frontiers in psychiatry · 2022-12-31 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01 Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08 P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary EfficacyBiological Psychiatry · 2022-04-27 Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?Military Medicine · 2022-04-20 Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signalingThe FASEB Journal · 2021-04-30 Binding Interactions of Psilocin and Serotonin in the 5-HT2A ReceptorVTechWorks (Virginia Tech) · 2020-05-04 Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.Unknown journal · 2011-10-25 Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.Unknown journal · 1997-12-31

Author directory